RAGE has potential pathogenetic and prognostic value in nonintubated hospitalized patients with COVID-19

BACKGROUND: The value of the soluble receptor for advanced glycation end-products (sRAGE) as a biomarker in COVID-19 is not well understood. We tested the association between plasma sRAGE and illness severity, viral burden, and clinical outcomes in hospitalized patients with COVID-19 who were not me...

Descripción completa

Detalles Bibliográficos
Autores principales: Wick, Katherine D., Siegel, Lianne, Neaton, James D., Oldmixon, Cathryn, Lundgren, Jens, Dewar, Robin L., Lane, H. Clifford, Thompson, B. Taylor, Matthay, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090244/
https://www.ncbi.nlm.nih.gov/pubmed/35298440
http://dx.doi.org/10.1172/jci.insight.157499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090244/
https://www.ncbi.nlm.nih.gov/pubmed/35298440
http://dx.doi.org/10.1172/jci.insight.157499

Ejemplares similares